SPONSOR
Zhejiang Wenda Pharma Technology LTD.
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Zhejiang Wenda Pharma Technology LTD. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Moderate to Severe Plaque Psoriasis, Brief Description of Focus of Study.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhejiang Wenda Pharma Technology LTD.
How many clinical trials has Zhejiang Wenda Pharma Technology LTD. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Zhejiang Wenda Pharma Technology LTD., of which 2 are actively recruiting participants. These trials cover conditions including Moderate to Severe Plaque Psoriasis, Brief Description of Focus of Study. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhejiang Wenda Pharma Technology LTD. research focus on?
Zhejiang Wenda Pharma Technology LTD. clinical trials span Moderate to Severe Plaque Psoriasis, Brief Description of Focus of Study. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhejiang Wenda Pharma Technology LTD. clinical trial?
To participate in a Zhejiang Wenda Pharma Technology LTD. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhejiang Wenda Pharma Technology LTD. trials with current recruitment status updated daily.
Clinical Trials by Zhejiang Wenda Pharma Technology LTD.
NCT07672561 Phase 3
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis
Moderate to Severe Plaque Psoriasis
NCT06912165 Phase 2
Recruiting
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
Brief Description of Focus of Study
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology